Thrombin activatable fibrinolysis inhibitor( TAFI )ELISA kit

Thrombin activatable fibrinolysis inhibitor( TAFI )ELISA kit

Size

one plate of 96 wells per kit

Catalog no.

E13651710

Price

670 EUR

Buy

Species reactivity

Human (Homo sapiens)

Product type

Immunoassays, ELISA kits

Recognized antigen

Thrombin activatable fibrinolysis inhibitor( TAFI )

Test

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Long Name

Human Thrombin activatable fibrinolysis inhibitor( TAFI )ELISA kit

Properties

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays

Laboratory tips

Small volumes from the liquid components of the Thrombin activatable fibrinolysis inhibitor( TAFI )EIA kit may get caught on the walls and lid of the vials. Prior to use, briefly centrifuge the vial to ensure that all of the content is gathered on the bottom.

Description

The Human Thrombin activatable fibrinolysis inhibitor( TAFI )ELISA kit is a ready to use kit manufactured by using high quality antibodies sets, plates, solutions and detection molecules. This EIA test for Human Thrombin activatable fibrinolysis inhibitor( TAFI ) will yield accurate and reproducible results. The specially designed buffers ensure the most suitable conditions for the detection reactions.

Storage conditions

Store all components and reagents of the Thrombin activatable fibrinolysis inhibitor( TAFI )ELISA kit refrigerated and +4 degrees Celcius. For a long term storage the kit's components may be frozen at -20 but cycles of freezing and thawing should be strictly avoided as they denaturate the polypeptide chains in the antibodies and controlls, thus causing a reduction in the kit's detection ability and specificity which changes will lead to inconsistant results.

Additional description

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.